Oppenheimer Reiterates "Outperform" Rating for Centene (NYSE

Oppenheimer Reiterates "Outperform" Rating for Centene (NYSE:CNC)

Centene (NYSE:CNC – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at Oppenheimer in a research report issued on Monday, Benzinga reports. They currently have a $110.00 target price on the stock. Oppenheimer’s price objective suggests a potential upside of 48.59% from the company’s previous close. A number of other equities […]

Related Keywords

Boston , Massachusetts , United States , Kennethj Fasola , Lori Jean Robinson , Barclays , Cantor Fitzgerald , Invesco Ltd , Morgan Stanley , Harris Associates , Centene Company Profile , Norges Bank , Centene Corporation , Wells Fargo Company , Get Free Report , Director Lori Jean Robinson , President Kenneth , Centene Daily , Centene , Nyse Cnc , Cnc , Medical , 15135b10 , Reiterated Rating , Oppenheimer Holdings Inc ,

© 2025 Vimarsana